The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 228.50
Bid: 228.50
Ask: 229.00
Change: 1.00 (0.44%)
Spread: 0.50 (0.219%)
Open: 228.00
High: 232.00
Low: 228.00
Prev. Close: 227.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Mondi and Smurfit Kappa raised, DS Smith cut

Thu, 13th Oct 2022 10:14

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

Goldman Sachs raises Sage Group price target to 810 (760) pence - 'neutral'

----------

Barclays cuts Schroders price target to 490 (520) pence - 'equal weight'

----------

JPMorgan cuts St James's Place price target to 1,040 (1,380) pence - 'neutral'

----------

Jefferies raises London Stock Exchange target to 10,000 (9,800) pence - 'buy'

----------

JPMorgan raises London Stock Exchange target to 9,700 (9,500) pence - 'overweight'

----------

RBC starts Unite Group with 'outperform' - price target 1,025 pence

----------

Goldman Sachs cuts Vodafone price target to 160 (175) pence - 'conviction buy list'

----------

Bank of America raises Rio Tinto price target to 7,000 (6,600) pence - 'buy'

----------

Goldman Sachs raises Rio Tinto price target to 6,300 (5,700) pence - 'buy'

----------

Bank of America raises Glencore price target to 520 (480) pence - 'neutral'

----------

Goldman Sachs raises Glencore price target to 700 (610) pence - 'buy'

----------

Bank of America raises Antofagasta price target to 1,100 (1,000) pence - 'underperform'

----------

Goldman Sachs raises Antofagasta price target to 1,200 (1,160) pence - 'neutral'

----------

Morgan Stanley cuts Antofagasta price target to 1,220 (1,240) pence - 'underweight'

----------

Goldman Sachs raises Anglo American price target to 4,000 (3,700) pence - 'buy'

----------

Bank of America cuts Anglo American price target to 2,800 (2,900) pence - 'neutral'

----------

Bank of America cuts Fresnillo to 'neutral' (buy) - price target 790 (810) pence

----------

Morgan Stanley cuts DS Smith to 'equal-weight' (overweight) - price target 340 (420) pence

----------

Morgan Stanley raises Smurfit Kappa to 'overweight' (equal-weight) - price target 3,200 (4,500) pence

----------

Morgan Stanley raises Mondi to 'overweight' (equal-weight) - price target 1,800 pence

----------

Goldman Sachs cuts SSE price target to 2,048 (2,151) pence - 'buy'

----------

Goldman Sachs cuts Severn Trent price target to 2,374 (2,777) pence - 'sell'

----------

Goldman Sachs cuts United Utilities price target to 994 (1,111) pence - 'neutral'

----------

JPMorgan raises BP price target to 530 (520) pence - 'neutral'

----------

JPMorgan cuts Shell price target to 2,900 (3,000) pence - 'overweight'

----------

Goldman Sachs reinitiates Informa with 'buy' - price target 775 pence

----------

FTSE 250

----------

Bank of America raises Ferrexpo price target to 150 (140) pence - 'underperform'

----------

Bank of America cuts Centamin price target to 140 (150) pence - 'buy'

----------

Morgan Stanley cuts JD Wetherspoon target to 700 (790) pence - 'equal-weight'

----------

Goldman Sachs cuts Pennon price target to 1,016 (1,250) pence - 'neutral'

----------

Numis raises Playtech to 'buy' ('add')

----------

Berenberg cuts Tui price target to 100 (180) pence - 'sell'

----------

Bank of America cuts Asos price target to 480 (540) pence - 'underperform'

----------

Barclays cuts Marks & Spencer price target to 165 (215) pence - 'overweight'

----------

JPMorgan cuts Marks & Spencer price target to 100 (120) pence - 'neutral'

----------

Jefferies reinitiates PureTech Health with 'buy' - price target 500 pence

----------

Barclays raises Man Group price target to 290 (280) pence - 'equal weight'

----------

Barclays cuts Lancashire Holdings price target to 550 (557) pence - 'equal weight'

----------

JPMorgan raises Lancashire price target to 640 (620) pence - 'overweight'

----------

Barclays cuts Hiscox price target to 1,208 (1,212) pence - 'equal weight'

----------

JPMorgan raises Hiscox price target to 900 (880) pence - 'underweight'

----------

Barclays raises Beazley price target to 789 (780) pence - 'overweight'

----------

JPMorgan raises Beazley price target to 800 (715) pence - 'overweight'

----------

JPMorgan places Quilter on 'negative catalyst watch'

----------

JPMorgan cuts Quilter price target to 85 (110) pence - 'neutral'

----------

Barclays cuts Ashmore price target to 280 (290) pence - 'overweight'

----------

RBC cuts IntegraFin price target to 295 (330) pence - 'sector perform'

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Goldman Sachs raises BHP rice target to 2,400 (2,000) pence - 'neutral'

----------

Berenberg cuts Tharisa price target to 240 (250) pence - 'buy'

----------

Bank of America cuts Hochschild Mining price target to 130 (140) pence - 'buy'

----------

Bank of America cuts Atalaya Mining price target to 250 (300) pence - 'neutral'

----------

Bank of America raises Yellow Cake price target to 640 (540) pence - 'buy'

----------

Bank of America cuts Petra Diamonds price target to 170 (180) pence - 'buy'

----------

Barclays cuts Kingspan price target to 48 (57) EUR - 'underweight'

----------

Jefferies cuts N Brown price target to 25 (30) pence - 'hold'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2022 07:54

LONDON BRIEFING: Bank of England widens bond buying; UK jobless down

(Alliance News) - The mood in global markets remained dark early Tuesday, with poor sessions in New York and Asia set to spill over to the European open.

Read more
11 Oct 2022 07:05

Puretech, Nektar Therapeutics end merger talks

(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.

Read more
7 Oct 2022 09:51

TOP NEWS: PureTech Health in merger talks with Nektar Therapeutics

(Alliance News) - Clinical-stage biotherapeutics firm PureTech Health PLC on Friday confirmed it is in combination talks with San Francisco-based biopharmaceutical company Nektar Therapeutics Inc.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.